Efficacy and safety of ultrasound-guided radiofrequency ablation for papillary thyroid microcarcinoma: a systematic review and meta-analysis

References

• Yi K, Kim S, Kim DH, et al. The Korean guideline for thyroid cancer screening. J Korean Med Assoc. 2015;58(4):302.
   Google Scholar
• Silver Karcioglu A, Iwata AJ, Pusztaszeri M, et al. The American thyroid association (ATA) integrates molecular testing into its framework for managing patients with anaplastic thyroid carcinoma (ATC): update on the 2021 ATA ATC guidelines. Cancer Cytopathol. 2022;130(3):174–180.
   PubMed Web of Science ®Google Scholar
• Lloyd RV, Buehler D, Khanafshar E. Papillary thyroid carcinoma variants. Head Neck Pathol. 2011;5(1):51–56.
   PubMedGoogle Scholar
• Gubbiotti MA, Livolsi V, Montone K, et al. Papillary thyroid microcarcinomas: does subtyping predict aggressive clinical behavior? Hum Pathol. 2021;114:28–35.
   PubMed Web of Science ®Google Scholar
• Elliott MS, Gao K, Gupta R, et al. Management of incidental and non-incidental papillary thyroid microcarcinoma. J Laryngol Otol. 2013;127(S2):S17–S23.
   PubMed Web of Science ®Google Scholar
• Patel SG, Carty SE, Lee AJ. Molecular testing for thyroid nodules including its interpretation and use in clinical practice. Ann Surg Oncol. 2021;28(13):8884–8891.
   PubMed Web of Science ®Google Scholar
• Zhang M, Tufano RP, Russell JO, et al. Ultrasound-guided radiofrequency ablation versus surgery for low-risk papillary thyroid microcarcinoma: results of over 5 years’ follow-up. Thyroid. 2020;30(3):408–417.
   PubMed Web of Science ®Google Scholar
• Koshkina A, Fazelzad R, Sugitani I, et al. Sawka, association of patient age with progression of low-risk papillary thyroid carcinoma under active surveillance: a systematic review and Meta-analysis. JAMA Otolaryngol Head Neck Surg. 2020;146(6):552–560.
   PubMed Web of Science ®Google Scholar
• Ha EJ, Baek JH, Lee JH, et al. Radiofrequency ablation of benign thyroid nodules does not affect thyroid function in patients with previous lobectomy. Thyroid. 2013;23(3):289–293.
   PubMed Web of Science ®Google Scholar
• Hamidi O, Callstrom MR, Lee RA, et al. Outcomes of radiofrequency ablation therapy for large benign thyroid nodules: a Mayo clinic case series. Mayo Clin Proc. 2018;93(8):1018–1025.
   PubMed Web of Science ®Google Scholar
• Lee GM, You JY, Kim HY, et al. Successful radiofrequency ablation strategies for benign thyroid nodules. Endocrine. 2019;64(2):316–321.
   PubMed Web of Science ®Google Scholar
• Choi Y, Jung SL, Bae JS, et al. Comparison of efficacy and complications between radiofrequency ablation and repeat surgery in the treatment of locally recurrent thyroid cancers: a single-center propensity score matching study. Int J Hyperthermia. 2019;36(1):359–367.
   PubMed Web of Science ®Google Scholar
• Mauri G, Hegedüs L, Bandula S, et al. European thyroid association and cardiovascular and interventional radiological society of Europe 2021 clinical practice guideline for the use of minimally invasive treatments in malignant thyroid lesions. Eur Thyroid J. 2021;10(3):185–197.
   PubMed Web of Science ®Google Scholar
• Wei Y, Niu WQ, Zhao ZL, et al. Microwave ablation versus surgical resection for solitary T1N0M0 papillary thyroid carcinoma. Radiology. 2022;304(3):704–713. )
   PubMed Web of Science ®Google Scholar
• Slim K, Nini E, Forestier D, et al. Methodological index for non-randomized studies (minors): development and validation of a new instrument. ANZ J Surg. 2003;73(9):712–716.
   PubMed Web of Science ®Google Scholar
• Zhang M, Luo Y, Zhang Y, et al. Efficacy and safety of Ultrasound-Guided radiofrequency ablation for treating low-risk papillary thyroid microcarcinoma: a prospective study. Thyroid. 2016;26(11):1581–1587.
   PubMed Web of Science ®Google Scholar
• Ding M, Tang X, Cui D, et al. Clinical outcomes of ultrasound-guided radiofrequency ablation for the treatment of primary papillary thyroid microcarcinoma. Clin Radiol. 2019;74(9):712–717.
   PubMed Web of Science ®Google Scholar
• Wu R, Luo Y, Tang J, et al. Ultrasound-guided radiofrequency ablation for papillary thyroid microcarcinoma: a retrospective analysis of 198 patients. Int J Hyperthermia. 2020;37(1):168–174.
   PubMed Web of Science ®Google Scholar
• Cho SJ, Baek SM, Lim HK, et al. Long-term follow-up results of ultrasound-guided radiofrequency ablation for low-risk papillary thyroid microcarcinoma: more than 5-year follow-up for 84 tumors. Thyroid. 2020;30(12):1745–1751.
   PubMed Web of Science ®Google Scholar
• Zhu Y, Che Y, Gao S, et al. Long-term follow-up results of PTMC treated by ultrasound-guided radiofrequency ablation: a retrospective study. Int J Hyperthermia. 2021;38(1):1225–1232.
   PubMed Web of Science ®Google Scholar
• He H, Song Q, Lan Y, et al. Efficacy and safety of ultrasound-guided radiofrequency ablation for low-risk papillary thyroid microcarcinoma in patients aged 55 years or older: a retrospective study. Int J Hyperthermia. 2021;38(1):604–610.
   PubMed Web of Science ®Google Scholar
• Lim LS, Lin WC, Chiang PL, et al. One year follow-up of US-Guided radiofrequency ablation for low-risk papillary thyroid microcarcinoma: the first experience in Taiwan. J Formos Med Assoc. 2021;121:1406–1413.
   PubMed Web of Science ®Google Scholar
• Song Q, Gao H, Tian X, et al. Evaluation of ultrasound-guided radiofrequency ablation as a treatment option for papillary thyroid microcarcinoma in the isthmus: a retrospective study. Front Endocrinol (Lausanne). 2020;11:599471.
   PubMed Web of Science ®Google Scholar
• Zhang C, Yin J, Hu C, et al. Comparison of ultrasound guided percutaneous radiofrequency ablation and open thyroidectomy in the treatment of low-risk papillary thyroid microcarcinoma: a propensity score matching study. Clin Hemorheol Microcirc. 2022;80(2):73–81.
   PubMed Web of Science ®Google Scholar
• Yan L, Zhang M, Song Q, et al. Ultrasound-Guided radiofrequency ablation versus thyroid lobectomy for low-risk papillary thyroid microcarcinoma: a propensity-matched cohort study of 884 patients. Thyroid. 2021;31(11):1662–1672.
   PubMed Web of Science ®Google Scholar
• Geisbush TR, Dymon Z, Gabriel MS, et al. A multimodal and pathological analysis of a renal cell carcinoma metastasis to the thyroid gland 11 years post nephrectomy. J Radiol Case Rep. 2019;13:1–9.
   PubMed Web of Science ®Google Scholar
• Gharib H, Papini E, Garber JR, et al. A.A.A.T.F.o.T. nodules, American Association of clinical endocrinologists, American college of endocrinology, and associazione medici endocrinologi medical guidelines for clinical practice for the diagnosis and management of thyroid nodules–2016 update. Endocr Pract. 2016;22:622–639.
   PubMed Web of Science ®Google Scholar
• Haugen BR, Alexander EK, Bible KC, et al. American thyroid association management guidelines for adult patients with thyroid nodules and differentiated thyroid cancer: the American thyroid association guidelines task force on thyroid nodules and differentiated thyroid cancer. Thyroid. 2016;26(1):1–133.
   PubMed Web of Science ®Google Scholar
• Farkas EA, King TA, Bolton JS, et al. A comparison of total thyroidectomy and lobectomy in the treatment of dominant thyroid nodules. Am Surg. 2002;68(8):678–682.
   PubMed Web of Science ®Google Scholar
• Wormald R, Sheahan P, Rowley S, et al. Hemithyroidectomy for benign thyroid disease: who needs follow-up for hypothyroidism? Clin Otolaryngol. 2008;33(6):587–591.
   PubMed Web of Science ®Google Scholar
• McHenry CR, Slusarczyk SJ. Hypothyroidisim following hemithyroidectomy: incidence, risk factors, and management. Surgery. 2000;128(6):994–998.
   PubMed Web of Science ®Google Scholar
• Teng D, Sui G, Liu C, et al. Long-term efficacy of ultrasound-guided low power microwave ablation for the treatment of primary papillary thyroid microcarcinoma: a 3-year follow-up study. J Cancer Res Clin Oncol. 2018;144(4):771–779.
   PubMed Web of Science ®Google Scholar
• van Dijk SPJ, Coerts HI, Gunput STG, et al. Assessment of radiofrequency ablation for papillary microcarcinoma of the thyroid: a systematic review and meta-analysis. JAMA Otolaryngol Head Neck Surg. 2022;148(4):317–325.
   PubMed Web of Science ®Google Scholar
• Yan Q, Prasla S, Carlisle DC, et al. Deep venous arterialization for chronic limb threatening ischemia in atherosclerosis patients - A meta-analysis. Ann Vasc Surg. 2022;81:1–21.
   PubMed Web of Science ®Google Scholar
• Solbiati L, Ierace T, Tonolini M, et al. Guidance and monitoring of radiofrequency liver tumor ablation with contrast-enhanced ultrasound. Eur J Radiol. 2004;51:S19–S23.
   PubMed Web of Science ®Google Scholar
• Kim JH, Baek JH, Lim HK, et al. Summary of the 2017 thyroid radiofrequency ablation guideline and comparison with the 2012 guideline. Ultrasonography. 2019;38(2):125–134.
   PubMed Web of Science ®Google Scholar